We are live on ! Find out more
ALBO

Albireo Pharma Inc

Delisted

ALBO was delisted on the 2nd of March, 2023.

42 hedge funds and large institutions have $47.8M invested in Albireo Pharma Inc in 2013 Q2 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more call options, than puts

Call options by funds: $1.46M | Put options by funds: $1.16M

Holders
42
Holders Change
+42
Holders Change %
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
42
Increased
Reduced
Closed
Calls
$1.46M
Puts
$1.16M
Net Calls
+$304K
Net Calls Change
+$304K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ALBO Hedge Fund Activity: Q2 2013 in Review

42 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2013, worth a combined $47.8M.

Buyers outnumbered sellers: 42 funds opened new ALBO positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

  • 42 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $47.8M of Albireo Pharma Inc stock for Q2 2013.
  • 42 funds opened new Albireo Pharma Inc positions in Q2 2013 and 0 closed out, a net change of +42 holders.

Based on aggregated 13F filings for Q2 2013.